Evidence map›Paper›PMID 36063052›Full record

ArticleBioinformatics (Oxford, England)2022

ABEILLE: a novel method for ABerrant Expression Identification empLoying machine LEarning from RNA-sequencing data.

Justine Labory, Gwendal Le Bideau, David Pratella, Jean-Elisée Yao, Samira Ait-El-Mkadem Saadi, Sylvie Bannwarth, Loubna El-Hami, Véronique Paquis-Fluckinger, Silvia Bottini

Open access · hybridAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Challenges and opportunities to bridge translational to clinical research for personalized mitochondrial medicine.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Justine LaboryUniversité Côte d'Azur, Center of Modeling, Simulation and Interactions, Nice 06000, France.
Gwendal Le BideauUniversité Côte d'Azur, Inserm U1081, CNRS UMR 7284, Institute for Research on Cancer and Aging, Nice (IRCAN), Centre Hospitalier Universitaire (CHU) de Nice, Nice 06200, France.
David PratellaUniversité Côte d'Azur, Center of Modeling, Simulation and Interactions, Nice 06000, France.
Jean-Elisée YaoUniversité Côte d'Azur, Center of Modeling, Simulation and Interactions, Nice 06000, France.
Samira Ait-El-Mkadem SaadiUniversité Côte d'Azur, Inserm U1081, CNRS UMR 7284, Institute for Research on Cancer and Aging, Nice (IRCAN), Centre Hospitalier Universitaire (CHU) de Nice, Nice 06200, France.
Sylvie BannwarthUniversité Côte d'Azur, Inserm U1081, CNRS UMR 7284, Institute for Research on Cancer and Aging, Nice (IRCAN), Centre Hospitalier Universitaire (CHU) de Nice, Nice 06200, France.
Loubna El-HamiUniversité Côte d'Azur, Center of Modeling, Simulation and Interactions, Nice 06000, France.
Véronique Paquis-FluckingerUniversité Côte d'Azur, Inserm U1081, CNRS UMR 7284, Institute for Research on Cancer and Aging, Nice (IRCAN), Centre Hospitalier Universitaire (CHU) de Nice, Nice 06200, France.
Silvia BottiniUniversité Côte d'Azur, Center of Modeling, Simulation and Interactions, Nice 06000, France.ORCID 0000-0002-0605-4646
Centre National de la Recherche Scientifique · FRUniversité Côte d'Azur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationCurrent advances in omics technologies are paving the diagnosis of rare diseases proposing a complementary assay to identify the responsible gene. The use of transcriptomic data to identify aberrant gene expression (AGE) has demonstrated to yield potential pathogenic events. However, popular approaches for AGE identification are limited by the use of statistical tests that imply the choice of arbitrary cut-off for significance assessment and the availability of several replicates not always possible in clinical contexts.

resultsHence, we developed ABerrant Expression Identification empLoying machine LEarning from sequencing data (ABEILLE) a variational autoencoder (VAE)-based method for the identification of AGEs from the analysis of RNA-seq data without the need for replicates or a control group. ABEILLE combines the use of a VAE, able to model any data without specific assumptions on their distribution, and a decision tree to classify genes as AGE or non-AGE. An anomaly score is associated with each gene in order to stratify AGE by the severity of aberration. We tested ABEILLE on a semi-synthetic and an experimental dataset demonstrating the importance of the flexibility of the VAE configuration to identify potential pathogenic candidates. AVAILABILITY AND IMPLEMENTATION: ABEILLE source code is freely available at: https://github.com/UCA-MSI/ABEILLE. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Machine LearningRNAExome SequencingSequence Analysis, RNASoftwareRNA

Identifiers

PMID36063052
PMCPMC9563686
OpenAlexW4294668246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.